grant

FEASIBILITY STUDIES, CLINICAL TRIAL READINESS, GMP/CLINICAL TRIAL MATERIALS

Organization ALBANY MOLECULAR RESEARCH, INC.Location ALBANY, UNITED STATESPosted 7 Jul 2022Deadline 6 Jul 2027
NIHUS FederalResearch GrantFY2022Clinical TrialsDrugsFeasibility StudiesFormulationHEAL InitiativeHelping End Addiction Long-termHelping End Addiction LongtermHelping to End Addiction Long-termHelping to End Addiction LongtermMedicationNational Institutes of HealthPainPain ControlPain TherapyPain managementPainfulPharmaceutic PreparationsPharmaceutical PreparationsSpeedUnited States National Institutes of Healthclinical painclinical trial readinessdrug/agentpain treatmentprograms
Sign up free to applyApply link · pipeline · email alerts
— or —

Get email alerts for similar roles

Weekly digest · no password needed · unsubscribe any time

Full Description

This study is part of the NIH’s Helping to End Addiction Long-term (HEAL) initiative to speed scientific solutions to understand the basis of pain and enhance clinical pain management.”

Drug Manufacturing and Formulation Program; FEASIBILITY STUDIES; CLINICAL TRIAL READINESS; Good Manufacturing Practice; CLINICAL TRIAL MATERIALS

Grant Number: 271201500005I-0-759502200001-1
NIH Institute/Center: NIH

Principal Investigator: MELISSA ALLARD

Sign up free to get the apply link, save to pipeline, and set email alerts.

Sign up free →

Agency Plan

7-day free trial

Unlock procurement & grants

Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.

$29.99 / month

  • 🔔Email alerts for new matching tenders
  • 🗂️Track tenders in your pipeline
  • 💰Filter by contract value
  • 📥Export results to CSV
  • 📌Save searches with one click
Start 7-day free trial →